Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Harrison, , Roy,
DOB:	02-OCT-1969 (Age: 56)
Gender:	male
Address:	Flat 4 Dyer route BA1 Baileyville (United Kingdom)
ID:	7093-553922-4 (ECI)

Report
Date:	30-MAR-2021

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Evelina Children's Hospital SE1 7 London (United Kingdom)

Specimen
Collected:	30-MAR-2021

Hematology

Test	30-MAR-2021	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	7.1	3.4 - 10.6	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	4.9	4.5 - 6.2	10*6/uL
Hemoglobin [Mass/volume] in Blood	13.0 L	13.5 - 17.5	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	44.0	38 - 50	%
MCV [Entitic volume] by Automated count	83.9	80 - 105	fL
MCH [Entitic mass] by Automated count	31.9	27 - 34	pg
MCHC [Mass/volume] by Automated count	33.8	31.5 - 36	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	42.2	36 - 55	fL
Platelets [#/volume] in Blood by Automated count	299.3	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	439.8 H	13.4 - 17.4	fL
Platelet mean volume [Entitic volume] in Blood by Automated count	10.4	9.8 - 13.8	fL

Chemistry

Test	30-MAR-2021	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	7.0 H	4.6 - 6	%
Glucose [Mass/volume] in Blood	116.9 H	70 - 99	mg/dL
Urea nitrogen [Mass/volume] in Blood	18.2	7 - 50	mg/dL
Creatinine [Mass/volume] in Blood	1.1	0.9 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	8.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	144.0	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.8	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	108.7	98 - 114	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	20.6 L	22 - 32	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	202.2 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	153.0 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	118.0	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	53.5	40 - 60	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	5.7	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows poor glycemic control (elevated HbA1c and fasting glucose), mild dyslipidemia (borderline high cholesterol and triglycerides), and mild anemia. Renal function and microalbuminuria are within normal limits. Low total CO₂ may suggest mild metabolic acidosis. Platelet count is normal, but platelet distribution width is elevated, which may indicate increased platelet variability. Clinical correlation and follow-up are recommended.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows poor glycemic control (elevated HbA1c and fasting glucose), mild dyslipidemia (borderline high cholesterol and triglycerides), and mild anemia. Renal function and microalbuminuria are within normal limits. Low total CO₂ may suggest mild metabolic acidosis. Platelet count is normal, but platelet distribution width is elevated, which may indicate increased platelet variability. Clinical correlation and follow-up are recommended.